Two Sigma Investments, LP Verona Pharma PLC Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Two Sigma Investments, LP holds 79,211 shares of VRNA stock, worth $6.43 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,211
Previous 152,104
47.92%
Holding current value
$6.43 Million
Previous $7.06 Million
28.8%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$533 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$448 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$319 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$281 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$235 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.95B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...